Early clinical studies are promising, but long-term safety, availability, and approval status still matter
Balancing Benefits with Safety Like all powerful therapies, retatrutide comes with considerations that patients and clinicians must weigh carefully
The average weight loss with Retatrutide exceeds 24%, meaning most users achieve cardiovascular risk reduction that would typically require multiple interventions
Does tirzepatide injection cause more heartburn than oral tirzepatide
M.PetrielloM
"This transition typically occurs when women are in their late 40s or 50s and is characterized by a significant decrease in the hormone estrogen." These changes can bring common symptoms, such as mood swings, hot flashes, skin changes, and more, which can alter your daily routine